Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Wants Pharma To Offer ‘Ever-Warm’ Vaccine & Drug Production Capacity

Facilities Would Be Quickly Available In Future Health Crises

Executive Summary

As part of its efforts to bolster Europe’s readiness for health emergencies, the European Commission wants to make sure that additional production capacity is available at short notice.

You may also be interested in...



EU Seeking Firms To Offer ‘Ever-Warm’ Production Capacity For Future Pandemics

The EU is drawing on lessons learned during the COVID-19 pandemic to set up a network of vaccine production capacities able to respond quickly to a surge in demand.

EU Launches New Response Body To Tackle Future Health Emergencies

The European Commission has dismissed concerns about the operation of its new emergency response body, saying it will ensure the EU is well prepared for tackling future pandemics and other threats. HERA will complement, not duplicate, work conducted by existing agencies such as the European Medicines Agency, delegates heard at this week’s European Health Forum Gastein virtual conference.

Major EU Research Project Targets Personalized Medicine, Unlocking Of Health Data

Neurodegenerative and cardiovascular diseases, along with cancer and early feasibility studies, are among the topics to be addressed by consortia interested in taking part in the EU’s latest research partnership.

Topics

Latest News
UsernamePublicRestriction

Register

PS145030

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel